{
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": true,
    "replication_method": "synthetic",
    "ucits": false,
    "type": "ETP",
    "complex_factors": "Leverage, Inverse, Synthetic Replication, Daily Rebalancing, Compounding Effect, High Risk Profile, No Capital Protection, Intended for Sophisticated Investors",
    "classification": "complex",
    "supporting_data": "The Leverage Shares -5x Short Nasdaq 100 ETP Securities are designed to deliver -5 times the daily performance of the Nasdaq-100 Index, using synthetic replication through a margin account holding collateral assets, securities loans, and cash. This structure introduces significant leverage and inverse exposure, which are inherently complex features under MiFID II. The product's daily rebalancing leads to a compounding effect that can result in returns significantly different from -5 times the index over periods longer than one day, a concept difficult for retail investors to understand. The ETP is explicitly intended for sophisticated investors who can monitor their investment frequently and understand the risks of compounded returns and inverse leveraged products. The product carries the highest risk indicator (7/7), offers no capital protection, and is not UCITS-compliant. These characteristicsu2014leverage, inverse strategy, synthetic replication, daily rebalancing, compounding, high risk, and lack of capital protectionu2014collectively make the product complex under MiFID II, as they go beyond the understanding of a retail investor with basic knowledge and introduce risks (e.g., counterparty, collateral, market, and compounding risks) that are not present in standard, physically replicated ETFs. The product's complexity is further underscored by the explicit warning in the KID that it 'is not simple and may be difficult to understand,' aligning with regulatory expectations for complex instruments."
}